BPC-157 is not registered as a drug in the EU or USA (clinical development PL 14736 halted at phase II in 2014) and has been on the WADA Prohibited List since 2022 in category S0 (non-approved substances)
Statistical analysis Statistical analyses were performed using SPSS (version 26
Safety Profile and Realistic Risk Assessment GHK-Cu demonstrates a generally favorable safety profile based on over 40 years of research, though most safety data derives from topical applications and animal studies
GHK-Cu supports skin remodeling and has antioxidant properties, but its research is cosmetic and wound-focused, not psoriasis-focused
This classification introduced in plants the Phi (replacing former Type I), Zeta (replacing former Type II), Tau (replacing former Type III), and Theta (replacing former Type IV) classes as well as two groups more distantly related to other known plant GSTs forming the Lambda (L) and dehydroascorbate reductase (DHAR) classes (Dixon et al., 2002)
Curr Opin Pediatr